Total compensation for seven CEOs of the largest commercial for-profit payers in the U.S. was about $151.3 million last year, according to proxy statements filed with the Securities and Exchange Commission.
Payer
Several health insurers are extending prior authorizations for elective services that have been canceled or deferred because of COVID-19.
Social, behavioral and environmental factors need to be incorporated into payment models that award providers for value over volume, according to a new paper published in the New England Journal of Medicine.
Rockford, Ill.-based Mercyhealth said it is no longer accepting patients who are insured by several private Medicaid insurers because of low reimbursement, according to local news station WIFR.
For Blue Cross and Blue Shield of Minnesota CEO Craig Samitt, MD, a pandemic didn't come to mind as a disruptor that would usher in changes like new prior authorization processes and telemedicine to the healthcare industry.
The Blue Cross Blue Shield Association, which represents 36 BCBS companies, has given almost $3 billion to healthcare workers, members and local communities to provide support during the COVID-19 pandemic.
A COVID-19 plasma treatment study led by Rochester, Minn.-based Mayo Clinic will get funding from UnitedHealth Group to help accelerate the federally sponsored program.
Centene Corp. subsidiary Centurion won a contract from the Kansas Department of Administration to run healthcare services for inmates in the state's correctional facilities.
Compensation for three top leaders at UnitedHealth Group totaled nearly $50 million in 2019, according to a proxy filing with the Securities and Exchange Commission.
Insurers offering commercial health plans to employers and individuals could issue roughly $2.7 billion in premium rebates this year, nearly double 2019's $1.4 billion record, the Kaiser Family Foundation said, citing data from Mark Farrah Associates.
